全球生命科学
概述
Featured News & Insights
0017
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort
Capabilities
Related Resources
Related Blogs
News & Insights
Swiss MedTech 2026Tuesday, August 25, 2026Sidley Adds Life Sciences Transactions Partner Jiqiang (JQ) Lin in New YorkAugust 12, 2026Shifting Expectations: FDA Takes a First Step Toward Making GRAS Notifications MandatoryAugust 12, 2026Managing IP Recognizes Sidley and 12 Lawyers in IP Stars 2026July 31, 2026
活动
新闻稿
Food, Drug and Medical Device Update
荣誉
Shifting Expectations: FDA Takes a First Step Toward Making GRAS Notifications MandatoryAugust 12, 2026The Evolving Global Landscape for Orphan Drug ExclusivityJuly 28, 2026OIG Signals Further Support for Manufacturer-Sponsored Testing Programs with Fourth Favorable Advisory OpinionJuly 8, 2026U.S. Clinical Trials: Federal Government Considers Safe Harbors to Encourage Enrollment and RetentionJuly 7, 2026
Food, Drug and Medical Device Update
Global Life Sciences Update
Global Life Sciences Update
Global Life Sciences Update
When AI Changes the Deal: Rethinking Risk, Milestones, and Timing in Life Sciences M&AJuly 29, 2026DOJ’s Civil Rights Fraud Initiative Raises False Claims Act Risks for Healthcare and Life Sciences CompaniesJune 4, 2026Securities Class Actions in the Life Sciences SectorSpring 2026Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market AccessApril 9, 2026
Life Science Leader
Reuters
出版专著
Westlaw Today
Sidley Adds Life Sciences Transactions Partner Jiqiang (JQ) Lin in New YorkAugust 12, 2026Sidley Wins Summary Judgment for Chemo Research, S.L. in Trade Secret and Unfair Competition CaseJuly 20, 2026Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026Sidley Adds Mayan Katz to Emerging Companies and Venture Capital and Global Life Sciences Practices in New YorkJuly 8, 2026
新闻稿
公告
公告
新闻稿
Managing IP Recognizes Sidley and 12 Lawyers in IP Stars 2026July 31, 2026Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026Sidley Highly Ranked in Chambers USA 2026June 4, 2026Sidley Wins Seven “Firm of the Year” Recognitions at the China Business Law AwardsMay 29, 2026
荣誉
荣誉
荣誉
荣誉
AI Collaborations – From Strategic License to Strategic AcquisitionJune 15, 2026The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN DealsMay 29, 2026FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight ParadigmMay 20, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci








































